Bacteriological, molecular and histopathological evaluation of four vaccines’ protective role against caseous lymphadenitis in sheep
Keywords:
Corynebacterium pseudotuberculosis, phospholipase D, molecular, histopathological, caseous lymphadenitis diseaseAbstract
The caseous lymphadenitis disease (CLA) due to Corynebacteriumpseudotuberculosis has worldwide distribution and indicates high prevalence in different countries. The bacterium has many pathogenicity factors; firstly, “phospholipase D”, an exotoxin virulence factor that enhances vascular permeability and facilitates bacterial transmission causing endothelial cell damage. The bacterium's exterior lipid cover is the second pathogenicity factor. This protects it from hydrolytic enzymes found in the phagocytes of the host, where the bacteria proliferate and then release after rupturing. Bacterial proliferation causes CLA abscesses, which are followed by attraction and the formation of an inflammatory response, which increases lymph flow and vascular permeability. The purpose of this study was to look atpostmortem findings, bacterial cultures, and histology of vaccinated sheep to see how well they were protected. On 15 male local sheep bread, four prepared vaccinations against C. pseudotuberculosis biotype 1 were tested. The animals were divided into 5 groups; four of various vaccines used and the fifthwere kept non-vaccinated. A live virulent strain of C. pseudotuberculosis was given to each group. Unvaccinated animals displayed CLA symptoms similar to those seen in spontaneously sick animals.
Downloads
References
Alcivar, M. S. G., Pérez, A. V., Gilert, B. I. C., & Gámez, M. R. (2017). Zeolite in wastewater decontamination as a local development solution. International Journal of Life Sciences, 1(3), 1–13. https://doi.org/10.21744/ijls.v1i3.52
Al-Gaabary MH, El-Sheikh WMA (2002). Epidemiological, clinical and preventive studies on caseous lymphadenitis in sheep and goats at Gharbia Governorate. In: 10th Scientific Congress of Faculty of Veterinary Medicine, Assiut University, Egypt;402–417.
Baird GJ, Fontaine MC (2007). Corynebacterium pseudotuberculosis and its role in ovine caseous lymphadenitis. Journal of Comparative Pathology 137: 179–210.
Batey RG, Speed CM,Kobes CJ (1986). Prevalence and distribution of caseous lymphadenitis in feral goats. Australian Veterinary Journal 63: 33–36.
Binns SH, Green LE, Bailey M (2007). Development and validation of an ELISA to detect antibodies to Corynebacterium pseudotuberculosis in ovine sera. Veterinary Microbiology 123:169–179.
Brogden KA, Chedid L, Cutlip RC, Lehmkuhl HD, Sacks J (1990). Effect of muramyl dipeptide on immunogenicity of Corynebacterium pseudotuberculosis whole cell vaccines in mice and lambs. American Journal of Veterinary Research 51: 200–202.
BrogdenKA, Cutlip RC,Lehmkuhl HD (1984). Experimental Corynebacterium pseudotuberculosis infection in lambs. American Journal of Veterinary Research 45: 1532-1534.
Brown CC, Olander HJ, Biberstein EL, Morse SM (1986). Use of a toxoid vaccine to protect goats against intradermal challenge exposure to Corynebacterium pseudotuberculosis. American Journal of Veterinary Research 47: 1116–1119.
Brown CC, Olander HJ,Alves SF (1987). Synergistic hemolysis inhibition titers associated with caseous lymphadenitis in a slaughter house survey of goat and sheep in North Eastern Brazil. Canadian Journal of Veterinary Research 51: 46–49.
Cetinkaya BM, Karahan E, Atil R, Kalin T,Vaneechoutte M (2002). Identification of Corynebacterium pseudotuberculosis isolates from sheep and goats by PCR. Veterinary Microbiology 88: 75-83.
Drury R, Wallington E (1980). Carlton’s Histopathological Technique, 4th ed. Oxford University Press, New York.
Eggleton DG, Doidge CV, Middleton HD, Minty DW (1991). Immunisation against ovine caseous lymphadenitis: efficacy of momocomponent Corynebacterium pseudotuberculosis toxoid vaccine and combined clostridial-corynebacterial vaccines. Australian Veterinary Journal 68: 320-1.
Flores-Díaz, Monturiol-Gross L, Naylor C, Alape-Girón A, Flieger A (2016). Bacterial Sphingomyelinases and Phospholipases as Virulence Factors. MicrobiolMolBiol Rev.80(3):597-628.
Fontaine MC, Baird G, Connor KM (2006).Vaccination confers significant protection of sheep against infection with a virulent United Kingdom of blood vessels. Nature 271: 246-8.
Fontaine MC, Baird GJ (2008). Caseous lymphadenitis. Small Ruminant Research 76:42–48.
Guilloteau L, Pépin M, Pardon P, Le Pape A (1990). Recruitment of 99m-technetium- or 111-indium labelledpolymorphonuclear leucocytes in experimentally induced pyogranulomas in lambs. Journal of Leukocyte Biology 48: 343–352.
Guimaraes AS, Carmo FB, Pauletti RB, Seyffert N, Ribeiro D, Lage AP, Heinemann MB, Miyoshi A, Azevedo V,Gouveia AMG (2011). Caseous lymphadenitis: epidemiology, diagnosis, and control. Institute of Integrative Omics and Applied Biotechnology Journal 2: 33-43.
Hard GC (1969). Electron microscopic study of the differentiation of mouse peritoneal macrophages stimulated by Corynebacterium ovis infection. Laboratory Investigation21: 309–315.
Khater AR, Deep S, Bayoumi AH, Salem H (1984). Studies on experimental infection with Corynebacterium pseudotuberculosis (ovis). III. Comparative studies on the effect of two strains in sheep. Assiut Veterinary Medicine Journal 11: 103–107.
Kuria JKN, Mbuthia PG, Kangethe EK,Wahome RG (2001). Caseous lymphadenitis in goats: the pathogenesis, incubation period and serological response after experimental infection. Veterinary Research Communication 25: 89–97.
Malone FE, Fee SA, Kamp EM, King DC, Baird GJ, Murdock FEA (2002). Postmortem and serological examinations of sheep in three flocks affected with caseous lymphadenitis. Proceedings of the Sheep Veterinary Society 26: 55–58.
Malone FE, Fee SA, Kamp EM, King DC, Baird GJ, O’Reilly KM, Murdock FEA (2006). Serological investigation of caseous lymphadenitis in four flocks of sheep. Irish Veterinary Journal 59, 19–21.
Mancini F, Monaco M, Pataracchia M, von Hunolstein C, Pantosti A,Ciervo A (2012). Identification and molecular discrimination of toxigenic and nontoxigenic diphtheria Corynebacterium strains by combined real-time polymerase chain reaction assays. Diagnostic Microbiology and Infectious Disease 73:111–120.
Modlin RL, Melancon-Kaplan J, Young SMM (1988). Learning from lesions: patterns of tissue inflammation in leprosy. Proceedings of the National Academy of Sciences, USA 85: 1213–1217.
Pepin M, Fontaine JJ, Pardon P, Marly J,Parodi AL (1991). Histopathology of the early phase during experimental Corynebacterium pseudotuberculosisinfection in lambs. Veterinary Microbiology 29: 123–134.
Pepin M, Pittet JC, Olivier M,Gohin I (1994b). Cellular composition of Corynebacteriumpseudotuberculosispyogranulomas in sheep. Journal of Leukocyte Biology 56: 666–670.
Pointon A, Hamilton D,Kiermeier A (2019). Comparison of postmortem inspection procedures for detecting caseous lymphadenitis of Australian sheep and goats. Veterinary Record 185:54.
Radostits OM, Gay CC, Hinchcliff KW and Constable PD, 2007. Veterinary medicine 10th edition. Saunders Elsevier, Philadelphia, pp 795–798.
Renshaw HW, Graff VP, Gates NL (1979). Visceral caseous lymphadenitis in thin ewe syndrome: isolation of Corynebacterium, Staphylococcus and Moroxella spp. from internal abscesses in emaciated ewes. American Journal Veterinary Research 40: 1110–1114.
Saragih, I. D., Suarilah, I., & Saragih, I. S. (2022). Prognosis of survival among older adults with COVID-19: A systematic review and meta-analysis. International Journal of Health Sciences, 6(S5), 4429–4444. https://doi.org/10.53730/ijhs.v6nS5.9576
Schlicher J, Schmitt S, Stevens MJA, Stephan R,Ghielmetti G (2021). Molecular Characterization of Corynebacterium pseudotuberculosis Isolated over a 15-Year Period in Switzerland. Veterinary Science 8:151.
Selim SA, Mousa WM, Mohamed KF, Moussa IM (2012). Synergistic hemolytic activity and its correlation to phospholipase D productivity by Corynebacterium pseudotuberculosis Egyptian isolates from sheep and buffalos. Brazalian Journal of Microbiology 2012:552-559.
Selim SA, Sohier MS, Eman AE, Effat MM, Hakim AS, Balata MA (2016). Evaluation of protective efficacy of mixed PLD toxoid and clostridial vaccines against Caseous Lymphadenitis (CLA) in Small Ruminants at Egypt. International Journal of Microbiological Research 7: 102-113.
Smith PB (2002). Large animal internal medicine, 3rd edition, Mosby, Inc., Missouri, pp 583–584 and 1078–1083.
Sohier MS (2006). Characterization of secretory proteins that secreted from Corynebacterium pseudotuberculosis. Giza, Egypt, 80p (Ph. D. Thesis. Bacteriology, Faculty of Veterinary Medicine, Cairo University.
Songer JG, Libby SJ, Iandolo JJ, Cuevas WA (1990). Cloning and expression of the phospholipase D gene from Corynebacteriumpseudotuberculosisin Escherichia coli. Infection and Immunity 58: 131-6.
Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021). Get vaccinated when it is your turn and follow the local guidelines. International Journal of Health Sciences, 5(3), x-xv. https://doi.org/10.53730/ijhs.v5n3.2938
Syame SM, Azza SMA, Eman SI, Hakim AS (2018). Evaluation of specific and non-specific immune response of four vaccines for caseous lymphadenitis in sheep challenged. Veterinary World 11: 1272–1276.
Syame SM, Selim SA, Bakry MA, Elgabry EA, Rehab MA (2017). Comparison of protection against caseous lymphadenitis in sheep induced by 16 local isolated strain of Corynebacteriumpseudotuberculosis by Toxoid PLD & Toxoid PLD with Bacterin vaccine. International Journal of Development Research. 7: 9.
TashjianJJ, Campbell SG (1983). Interaction between caprine macrophages and Corynebacteriumpseudotuberculosis: an electron microscopy study. American Journal Veterinary Research 44: 690–693.
Walker J, Jackson H, Brandon MR,Meeusen E (1991). Lymphocyte sub-populations in pyogranulomas of caseous lymphadenitis. Clinical Experimental Immunology 86: 13–18.
Williamson LH (2001). Caseous lymphadenitis in small ruminants. Veterinary Clinics of North America. Food Animal Practice 17: 359-71.
Zaituon AM,Bayoumi AH (1994). Some epidemiological studies on ovine pseudotuberculosis. Assiut Veterinary Medical Journal 31: 238–250.
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
